These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Does whole-body Patlak Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031 [TBL] [Abstract][Full Text] [Related]
5. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients. Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues. Povoski SP; Murrey DA; Smith SM; Martin EW; Hall NC BMC Cancer; 2014 Jun; 14():453. PubMed ID: 24942656 [TBL] [Abstract][Full Text] [Related]
7. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer. Oprea-Lager DE; Kramer G; van de Ven PM; van den Eertwegh AJ; van Moorselaar RJ; Schober P; Hoekstra OS; Lammertsma AA; Boellaard R J Nucl Med; 2016 May; 57(5):721-7. PubMed ID: 26697964 [TBL] [Abstract][Full Text] [Related]
8. Reproducibility and Repeatability of Semiquantitative Vargas HA; Kramer GM; Scott AM; Weickhardt A; Meier AA; Parada N; Beattie BJ; Humm JL; Staton KD; Zanzonico PB; Lyashchenko SK; Lewis JS; Yaqub M; Sosa RE; van den Eertwegh AJ; Davis ID; Ackermann U; Pathmaraj K; Schuit RC; Windhorst AD; Chua S; Weber WA; Larson SM; Scher HI; Lammertsma AA; Hoekstra OS; Morris MJ J Nucl Med; 2018 Oct; 59(10):1516-1523. PubMed ID: 29626121 [No Abstract] [Full Text] [Related]
9. Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks. Zaker N; Haddad K; Faghihi R; Arabi H; Zaidi H Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4048-4063. PubMed ID: 35716176 [TBL] [Abstract][Full Text] [Related]
10. Patlak Slope versus Standardized Uptake Value Image Quality in an Oncologic PET/CT Population: A Prospective Cross-Sectional Study. Ince S; Laforest R; Itani M; Prasad V; Ashrafinia S; Smith AM; Wahl RL; Fraum TJ Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732298 [TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response. Shankar LK; Huang E; Litiere S; Hoekstra OS; Schwartz L; Collette S; Boellaard R; Bogaerts J; Seymour L; deVries EGE Clin Cancer Res; 2023 Jan; 29(1):143-153. PubMed ID: 36302172 [TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy. Crombé A; Gauquelin L; Nougaret S; Chicart M; Pulido M; Floquet A; Guyon F; Croce S; Kind M; Cazeau AL Diagn Interv Imaging; 2021 Oct; 102(10):629-639. PubMed ID: 34112625 [TBL] [Abstract][Full Text] [Related]
13. Repeatability of SUV in Oncologic Lodge MA J Nucl Med; 2017 Apr; 58(4):523-532. PubMed ID: 28232605 [TBL] [Abstract][Full Text] [Related]
14. Variability and Repeatability of Quantitative Uptake Metrics in Zhuang M; García DV; Kramer GM; Frings V; Smit EF; Dierckx R; Hoekstra OS; Boellaard R J Nucl Med; 2019 May; 60(5):600-607. PubMed ID: 30389824 [TBL] [Abstract][Full Text] [Related]
15. Test-Retest Reproducibility of Kurland BF; Peterson LM; Shields AT; Lee JH; Byrd DW; Novakova-Jiresova A; Muzi M; Specht JM; Mankoff DA; Linden HM; Kinahan PE J Nucl Med; 2019 May; 60(5):608-614. PubMed ID: 30361381 [TBL] [Abstract][Full Text] [Related]
16. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
17. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [TBL] [Abstract][Full Text] [Related]
18. Test-Retest Variability in Lesion SUV and Lesion SUR in Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598 [TBL] [Abstract][Full Text] [Related]
20. Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies. Velasquez LM; Boellaard R; Kollia G; Hayes W; Hoekstra OS; Lammertsma AA; Galbraith SM J Nucl Med; 2009 Oct; 50(10):1646-54. PubMed ID: 19759105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]